SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 213 filers reported holding SHOCKWAVE MED INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80 | -29.8% | 400 | 0.0% | 0.02% | -24.2% |
| Q2 2023 | $114 | +31.0% | 400 | 0.0% | 0.03% | +32.0% |
| Q1 2023 | $87 | +6.1% | 400 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $82 | -99.9% | 400 | 0.0% | 0.02% | -30.6% |
| Q3 2022 | $111,000 | +46.1% | 400 | 0.0% | 0.04% | +56.5% |
| Q2 2022 | $76,000 | -8.4% | 400 | 0.0% | 0.02% | +4.5% |
| Q1 2022 | $83,000 | +16.9% | 400 | 0.0% | 0.02% | +22.2% |
| Q4 2021 | $71,000 | -13.4% | 400 | 0.0% | 0.02% | -21.7% |
| Q3 2021 | $82,000 | +7.9% | 400 | 0.0% | 0.02% | +4.5% |
| Q2 2021 | $76,000 | +46.2% | 400 | 0.0% | 0.02% | +22.2% |
| Q1 2021 | $52,000 | +26.8% | 400 | 0.0% | 0.02% | +12.5% |
| Q4 2020 | $41,000 | +36.7% | 400 | 0.0% | 0.02% | +23.1% |
| Q3 2020 | $30,000 | +57.9% | 400 | 0.0% | 0.01% | +44.4% |
| Q2 2020 | $19,000 | +46.2% | 400 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $13,000 | -27.8% | 400 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $18,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,857 | 8.92% |
| Atika Capital Management LLC | 122,593 | $25,206,347 | 3.62% |
| GILDER GAGNON HOWE & CO LLC | 705,880 | $145,135,955 | 2.71% |
| Alcosta Capital Management, Inc. | 10,470 | $2,152,737 | 2.17% |
| AtonRa Partners | 7,535 | $1,549,271 | 1.97% |
| Matisse Capital | 20,142 | $2,072,769 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 39,100 | $8,039,351 | 1.56% |
| Nicholas Investment Partners, LP | 84,507 | $17,375,484 | 1.52% |
| Biondo Investment Advisors, LLC | 31,238 | $6,422,845 | 1.43% |
| Seaport Global Advisors, LLC | 1,616 | $332,266 | 1.15% |